American Heart Association updates blood pressure guidance as heart problems rise in under-40s
New guidelines push earlier action and introduce a long-term risk calculator as experts warn younger people are increasingly affected by hypertension
The American Heart Association has overhauled its blood pressure guidance, urging earlier action to curb a rise in heart-related illness among younger adults and to reduce the long-term burden of cardiovascular disease.
Under the revamped recommendations, which mark the first substantive update since 2017, clinicians are being encouraged to emphasize prevention and earlier identification of high blood pressure. The association notes that hypertension—commonly defined by readings higher than 130/80 mm Hg—now affects an estimated one in four young adults aged 18 to 39, and a notable share of children and adolescents aged 8 to 19. Overall, roughly half of U.S. adults have high blood pressure.
Heart specialists involved in the update highlighted the need to "address the growing burden of morbidity and mortality attributable to high blood pressure," and to shift toward prevention rather than waiting for older age to begin treatment. The association has also introduced a tool called PREVENT (Predicting Risk of cardiovascular disease events), designed to estimate 10- and 30-year cardiovascular disease risk to help guide clinical decision-making over both the near and longer term.
The guidance change responds to data showing increasing rates of cardiovascular events and related conditions among younger populations. High blood pressure is a major risk factor for heart disease and stroke and is associated with other serious outcomes over time, including kidney disease, cognitive decline and dementia. Physicians say earlier attention to elevated readings can allow lifestyle interventions and, when appropriate, medical treatment to reduce cumulative cardiovascular risk.
The update reinforces systematic assessment of blood pressure in clinical encounters and consideration of broader risk when planning management. It calls for clinicians to use risk-estimation tools such as PREVENT to inform conversations about both short-term and decades-long risks, and to tailor prevention strategies to individual patients. The guidance also reasserts the value of routine screening in younger people, given the prevalence figures for adults and the presence of high readings in some children and adolescents.
Public health experts and clinicians have noted that the shift does not seek to medicalize large segments of the population without consideration; rather, it aims to identify those at heightened lifelong risk so that modifiable factors can be addressed earlier. Evidence links prolonged exposure to elevated blood pressure to more severe cardiovascular outcomes, and the association said the guidance prioritizes measures that could reduce those long-term harms.
The American Heart Association and participating specialists said they will provide clinicians with implementation resources and tools to integrate the guidance into practice. PREVENT and related materials are intended to support individualized discussions about risk and to help providers and patients weigh lifestyle modification, monitoring and, where indicated, pharmacologic treatment to lower blood pressure and reduce future cardiovascular events.